PURPOSE: Smudge cells are ruptured chronic lymphocytic leukemia (CLL) cells appearing on the blood smears of CLL patients. Our recent findings suggest that the number of smudge cells may have important biologic correlations rather than being only an artifact of slide preparation. In this study, we evaluated whether the smudge cell percentage on a blood smear predicted survival of CLL patients. PATIENTS AND METHODS: We calculated smudge cell percentages (ratio of smudged to intact cells plus smudged lymphocytes) on archived blood smears from a cohort of previously untreated patients with predominantly early-stage CLL enrolled onto a prospective observational study. The relationship between percentage of smudge cells, patient survival, and other prognostic factors was explored. RESULTS: Between 1994 and 2002, 108 patients were enrolled onto the study and had archived blood smears available for review; 80% of patients had Rai stage 0 or I disease. The median smudge cell percentage was 28% (range, 1% to 75%). The percentage of smudge cells was lower in CD38(+) versus CD38(-) patients (P = .019) and in Zap70-positive versus Zap70-negative patients (P = .028). Smudge cell percentage as a continuous variable was associated with prolonged survival (P = .042). The 10-year survival rate was 50% for patients with 30% or less smudge cells compared with 80% for patients with more than 30% of smudge cells (P = .015). In multivariate analysis, the percentage of smudge cells was an independent predictor of overall survival. CONCLUSION: Percentage of smudge cells on blood smear is readily available and an independent factor predicting overall survival in CLL.
PURPOSE: Smudge cells are ruptured chronic lymphocytic leukemia (CLL) cells appearing on the blood smears of CLL patients. Our recent findings suggest that the number of smudge cells may have important biologic correlations rather than being only an artifact of slide preparation. In this study, we evaluated whether the smudge cell percentage on a blood smear predicted survival of CLL patients. PATIENTS AND METHODS: We calculated smudge cell percentages (ratio of smudged to intact cells plus smudged lymphocytes) on archived blood smears from a cohort of previously untreated patients with predominantly early-stage CLL enrolled onto a prospective observational study. The relationship between percentage of smudge cells, patient survival, and other prognostic factors was explored. RESULTS: Between 1994 and 2002, 108 patients were enrolled onto the study and had archived blood smears available for review; 80% of patients had Rai stage 0 or I disease. The median smudge cell percentage was 28% (range, 1% to 75%). The percentage of smudge cells was lower in CD38(+) versus CD38(-) patients (P = .019) and in Zap70-positive versus Zap70-negative patients (P = .028). Smudge cell percentage as a continuous variable was associated with prolonged survival (P = .042). The 10-year survival rate was 50% for patients with 30% or less smudge cells compared with 80% for patients with more than 30% of smudge cells (P = .015). In multivariate analysis, the percentage of smudge cells was an independent predictor of overall survival. CONCLUSION: Percentage of smudge cells on blood smear is readily available and an independent factor predicting overall survival in CLL.
Authors: Laura Z Rassenti; Lang Huynh; Tracy L Toy; Liguang Chen; Michael J Keating; John G Gribben; Donna S Neuberg; Ian W Flinn; Kanti R Rai; John C Byrd; Neil E Kay; Andrew Greaves; Arthur Weiss; Thomas J Kipps Journal: N Engl J Med Date: 2004-08-26 Impact factor: 91.245
Authors: Remi Letestu; Andy Rawstron; Paolo Ghia; Neus Villamor; Nancy Boeckx; Nancy Boeckx Leuven; Sebastian Boettcher; Anne Mette Buhl; Jan Duerig; Rachel Ibbotson; Alexander Kroeber; Anton Langerak; Magali Le Garff-Tavernier; Ian Mockridge; Alison Morilla; Ruth Padmore; Laura Rassenti; Matthias Ritgen; Medhat Shehata; Piotr Smolewski; Peter Staib; Michel Ticchioni; Clare Walker; Florence Ajchenbaum-Cymbalista Journal: Cytometry B Clin Cytom Date: 2006-07-15 Impact factor: 3.058
Authors: Gordon W Dewald; Stephanie R Brockman; Sarah F Paternoster; Nancy D Bone; Judith R O'Fallon; Cristine Allmer; Charles D James; Diane F Jelinek; Renee C Tschumper; Curtis A Hanson; Rajiv K Pruthi; Thomas E Witzig; Timothy G Call; Neil E Kay Journal: Br J Haematol Date: 2003-04 Impact factor: 6.998
Authors: Marco Antonio Velasco-Velázquez; José Agramonte-Hevia; Diana Barrera; Alejandro Jiménez-Orozco; María Juana García-Mondragón; Nicandro Mendoza-Patiño; Abraham Landa; Juan Mandoki Journal: Cancer Lett Date: 2003-08-20 Impact factor: 8.679
Authors: Diane F Jelinek; Renee C Tschumper; Gustavo A Stolovitzky; Stephen J Iturria; Yuhai Tu; Jorge Lepre; Nigam Shah; Neil E Kay Journal: Mol Cancer Res Date: 2003-03 Impact factor: 5.852
Authors: P B Knudsen; B Hanna; S Ohl; L Sellner; T Zenz; H Döhner; S Stilgenbauer; T O Larsen; P Lichter; M Seiffert Journal: Leukemia Date: 2013-11-27 Impact factor: 11.528
Authors: Lílian G Teixeira; Alda J Leonel; Edenil C Aguilar; Nathália V Batista; Andréa C Alves; Candido C Coimbra; Adaliene V M Ferreira; Ana Maria C de Faria; Denise C Cara; Jacqueline I Alvarez Leite Journal: Lipids Health Dis Date: 2011-11-10 Impact factor: 3.876